THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

LOS ANGELES CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001177206)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 174,535 Value ($000) $2,496 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 181,477 Value ($000) $2,650 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 19,850 Value ($000) $219 Avg Close $9.72 Range $7.90 - $11.82

Q2 2024

Shares 33,760 Value ($000) $286 Avg Close $9.03 Range $8.13 - $10.44

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	174,535	$2,496	$16.59	$13.50 - $20.33
Q3 2025	181,477	$2,650	$12.64	$10.82 - $14.87
Q2 2025	19,850	$219	$9.72	$7.90 - $11.82
Q2 2024	33,760	$286	$9.03	$8.13 - $10.44